Nabriva Therapeutics AG (NBRV) PT Raised to $18 at Northland Capital Markets
Tweet
Share
E-mailGet Alerts NBRV Hot Sheet
Price: $1.42 --0%
Rating Summary:
4 Buy, 6 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Rating Summary:
4 Buy, 6 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Join SI Premium – FREE
Northland Capital Markets analyst Carl Byrnes raised the price target on Nabriva Therapeutics AG (NASDAQ: NBRV) to $18.00 (from $2.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Goldman Sachs Upgrades Plains GP Holdings, L.P (PAGP) to Neutral
- Meituan Dianping (3690:HK) (MPNGF) PT Lowered to HK$93 at Macquarie
- Otsuka Holdings Co Ltd. (4578:JP) (OTSKY) PT Raised to JPY11,000 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
